查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572286

Benexate 市場：按產品類型、配方、應用和最終用戶分類 - 全球預測 2025-2030

Benexate Market by Product Type (Benexate Hydrochloride, Benexate Hydrochloride Betadex), Formulation (Capsules, Injectables, Tablets), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

Benexate市場價值2023年為5.4934億美元，預計2024年將達到5.8438億美元，複合年成長率為6.85%，預計到2030年將達到8.7382億美元。

Benexate 是一種活性藥物成分，常用於治療消化性潰瘍和相關胃腸道疾病，並在製藥領域顯示出巨大的成長潛力。這種化合物的需求是由於胃腸道疾病的盛行率不斷增加以及全球醫療市場對有效藥物的持續需求。該化合物的應用範圍不僅限於潰瘍，還可以治療各種胃腸道疾病，凸顯了治療性介入的廣泛最終用途。市場促進因素包括新興國家老年人口的增加和醫療保健支出的增加。這些因素增加了對有效胃腸道治療的需求，並創造了潛在的擴張機會，特別是在醫療基礎設施正在迅速發展的亞太和拉丁美洲。公司可以透過投資當地產能和最佳化分銷網路來提高市場滲透率，從而利用這些機會。然而，嚴格的法律規範和與苯乙酯類產品相關的副作用等挑戰可能會阻礙成長。克服這些挑戰需要嚴格的臨床試驗和改進更安全的配方，這可以增強消費者的信心。創新可以採取開發先進的藥物輸送系統和聯合治療的形式，以提高療效和患者依從性。此外，個人化醫療方法的研究可能會開闢新的途徑並實現標靶治療解決方案，特別是對於患有複雜胃腸道病理的患者。考慮到這些競爭考察，Benexate 市場的性質是競爭性的，但創新的時機已經成熟，其中包括大型製藥企業和新興生物技術公司。希望獲得並維持市場佔有率的公司必須注重策略夥伴關係、先進的研發工作以及靈活的監管合規方法。總體而言，Benexate 市場需要積極的策略來推動成長，並透過創新和策略市場定位來應對機會和挑戰。

主要市場統計
基準年[2023] 5.4934 億美元
預測年份 [2024] 5.8438 億美元
預測年份 [2030] 87382萬美元
複合年成長率（%） 6.85%

市場動態：揭示快速發展的 Benexate 市場的關鍵市場洞察

Benexate 市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率的增加推動了治療市場對 Benexate 的需求
    • 不斷成長的醫療保健支出和有利的政府政策提振 Benexate 市場
    • 配方技術的進步增強了 Benexate 的功效和應用
    • 由於醫療基礎設施的改善，Benexate 在新興市場的認知度和採用率有所提高
  • 市場限制因素
    • 醫療專業人員對 Benexate 的益處和用途缺乏認知和理解
    • 市場上替代療法和治療方法的可用性影響了對基於 Benexate 的解決方案的需求
  • 市場機會
    • 在 Benexate 市場開拓專門針對老化社會需求的醫療服務和產品
    • 利用資料分析和人工智慧為 Benexate 消費者創建個人化金融服務
    • Benexate 投資可再生能源計劃，以滿足都市區不斷成長的能源需求
  • 市場問題
    • 客製化產品和服務以滿足 Benexate 市場中不同文化的消費者需求
    • 在影響 Benexate 市場的全球動盪中保持強勁的供應鏈效率

波特的五力：駕馭 Benexate 市場的策略工具

波特的五力框架是了解 Benexate 市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解 Benexate 市場的外部影響

外部宏觀環境因素在塑造 Benexate 市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 Benexate 市場的競爭狀況

Benexate 市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 Benexate 市場供應商的績效評估

FPNV 定位矩陣是評估 Benexate 市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 Benexate 市場的成功之路

Benexate 市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的增加正在增加治療市場對 Benexate 的需求
      • 不斷上漲的醫療費用和有利的政府政策正在推動 Benexate 市場
      • 藥物製劑的技術進步增強了 Benexate 的功效和應用
      • 醫療保健基礎設施的改善提高了 Benexate 在新興市場的認知度和採用率
    • 抑制因素
      • 醫療保健專業人員對 Benexate 的益處和用途的認知和理解有限。
      • 市場上替代療法和治療方法的可用性將影響對基於 Benexate 的解決方案的需求
    • 機會
      • 開發適合老化社會需求的專業醫療服務和產品 Benexate Market
      • 利用資料分析和人工智慧為 Benexert 消費者打造個人化金融服務
      • 投資可再生能源計劃，以滿足 Benexat都市區不斷成長的能源需求
    • 任務
      • Benexate Marketplace 客製化產品與服務，以滿足不同文化消費者的需求
      • 隨著全球顛覆影響全球經濟，Benexate 市場維持強勁的供應鏈效率
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 Benexate 市場：依產品類型

  • 介紹
  • 鹽酸苯乙酯
  • 鹽酸苯乙酯倍他葡糖

第 7 章 Benexate 市場：依配方分類

  • 介紹
  • 膠囊
  • 注射
  • 錠劑

第 8 章 Benexate 市場：依應用分類

  • 介紹
  • 心臟病學
  • 胃腸病學
    • 胃炎
    • 消化性潰瘍
  • 神經病學

第 9 章 Benexate 市場：依最終用戶分類

  • 介紹
  • 居家醫療
  • 醫院/診所
  • 研究所

第10章 美洲Benexate市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區 Benexate 市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲Benexate市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 1. Astellas Pharma Inc.
  • 2. Chugai Pharmaceutical Co., Ltd.
  • 3. Daiichi Sankyo Co., Ltd.
  • 4. Eisai Co., Ltd.
  • 5. Kyowa Kirin Co., Ltd.
  • 6. Meiji Seika Pharma Co., Ltd.
  • 7. Mitsubishi Tanabe Pharma Corporation
  • 8. Nichi-Iko Pharmaceutical Co., Ltd.
  • 9. Nipro Corporation
  • 10. Otsuka Pharmaceutical Co., Ltd.
  • 11. Sawai Pharmaceutical Co., Ltd.
  • 12. Shionogi & Co., Ltd.
  • 13. Takeda Pharmaceutical Company Limited
  • 14. Teijin Pharma Limited
  • 15. Towa Pharmaceutical Co., Ltd.
Product Code: MRR-1A1A064C01F6

The Benexate Market was valued at USD 549.34 million in 2023, expected to reach USD 584.38 million in 2024, and is projected to grow at a CAGR of 6.85%, to USD 873.82 million by 2030.

Benexate, an active pharmaceutical ingredient often used for treating peptic ulcers and related gastrointestinal issues, showcases a significant growth potential in the pharmaceutical sector. The necessity for this compound stems from the increasing prevalence of gastrointestinal disorders and the ongoing demand for effective medications in the global healthcare market. Its application extends beyond ulcers, encompassing the treatment of various digestive conditions, thus highlighting its versatile end-use scope in therapeutic interventions. Market insights reveal that the rising geriatric population, coupled with an increase in healthcare spending in emerging economies, are key growth drivers. These factors amplify the demand for effective gastrointestinal treatments, creating potential opportunities for expansion, particularly in Asia-Pacific and Latin America, where healthcare infrastructure is rapidly evolving. Companies can capitalize on these opportunities by investing in local manufacturing capabilities and optimizing distribution networks to enhance market penetration. However, challenges such as stringent regulatory frameworks and side-effect profiles associated with benexate-based products may impede growth. Overcoming these could involve rigorous clinical testing and improved safety formulations, thus encouraging consumer trust. Innovation can take the form of developing advanced drug delivery systems or combination therapies that improve efficacy and patient compliance. Moreover, research into personalized medicine approaches could open new avenues, allowing for targeted therapy solutions, particularly for patients with complex gastrointestinal pathologies. Given these insights, the nature of the benexate market is competitive yet ripe for innovation, characterized by a blend of established pharmaceutical giants and emerging biotech firms. Companies aiming to capture and sustain market share need to focus on strategic partnerships, advanced R&D endeavors, and an agile approach to regulatory compliance. Overall, the benexate market demands a proactive strategy to navigate its opportunities and challenges, propelling growth through innovation and strategic market positioning.

KEY MARKET STATISTICS
Base Year [2023] USD 549.34 million
Estimated Year [2024] USD 584.38 million
Forecast Year [2030] USD 873.82 million
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Benexate Market

The Benexate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases driving demand for benexate in the therapeutic market
    • Rising healthcare expenditure and favorable government policies boosting the benexate market
    • Technological advancements in drug formulation enhancing the efficacy and application of benexate
    • Growing awareness and adoption of benexate in emerging markets due to improved healthcare infrastructure
  • Market Restraints
    • Limited awareness and understanding among healthcare professionals about the benefits and usage of Benexate
    • The availability of alternative therapies and treatments in the market impacts the demand for Benexate-based solutions
  • Market Opportunities
    • Developing specialized healthcare services and products targeting the needs of aging population in Benexate market
    • Creating personalized financial services leveraging data analytics and AI for Benexate consumers
    • Investing in renewable energy projects to meet the increasing energy demands of Benexate's urban areas
  • Market Challenges
    • Tailoring products and services to meet culturally diverse consumer needs in the Benexate Market
    • Maintaining robust supply chain efficiencies amidst global disruptions impacting the Benexate Market

Porter's Five Forces: A Strategic Tool for Navigating the Benexate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Benexate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Benexate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Benexate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Benexate Market

A detailed market share analysis in the Benexate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Benexate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Benexate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Benexate Market

A strategic analysis of the Benexate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Benexate Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Meiji Seika Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nichi-Iko Pharmaceutical Co., Ltd., Nipro Corporation, Otsuka Pharmaceutical Co., Ltd., Sawai Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, and Towa Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Benexate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Benexate Hydrochloride and Benexate Hydrochloride Betadex.
  • Based on Formulation, market is studied across Capsules, Injectables, and Tablets.
  • Based on Application, market is studied across Cardiology, Gastroenterology, and Neurology. The Gastroenterology is further studied across Gastritis and Peptic Ulcers.
  • Based on End-User, market is studied across Homecare Settings, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases driving demand for benexate in the therapeutic market
      • 5.1.1.2. Rising healthcare expenditure and favorable government policies boosting the benexate market
      • 5.1.1.3. Technological advancements in drug formulation enhancing the efficacy and application of benexate
      • 5.1.1.4. Growing awareness and adoption of benexate in emerging markets due to improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and understanding among healthcare professionals about the benefits and usage of Benexate
      • 5.1.2.2. The availability of alternative therapies and treatments in the market impacts the demand for Benexate-based solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing specialized healthcare services and products targeting the needs of aging population in Benexate market
      • 5.1.3.2. Creating personalized financial services leveraging data analytics and AI for Benexate consumers
      • 5.1.3.3. Investing in renewable energy projects to meet the increasing energy demands of Benexate's urban areas
    • 5.1.4. Challenges
      • 5.1.4.1. Tailoring products and services to meet culturally diverse consumer needs in the Benexate Market
      • 5.1.4.2. Maintaining robust supply chain efficiencies amidst global disruptions impacting the Benexate Market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Benexate Market, by Product Type

  • 6.1. Introduction
  • 6.2. Benexate Hydrochloride
  • 6.3. Benexate Hydrochloride Betadex

7. Benexate Market, by Formulation

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Injectables
  • 7.4. Tablets

8. Benexate Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Gastroenterology
    • 8.3.1. Gastritis
    • 8.3.2. Peptic Ulcers
  • 8.4. Neurology

9. Benexate Market, by End-User

  • 9.1. Introduction
  • 9.2. Homecare Settings
  • 9.3. Hospitals & Clinics
  • 9.4. Research Institutes

10. Americas Benexate Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Benexate Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Benexate Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Chugai Pharmaceutical Co., Ltd.
  • 3. Daiichi Sankyo Co., Ltd.
  • 4. Eisai Co., Ltd.
  • 5. Kyowa Kirin Co., Ltd.
  • 6. Meiji Seika Pharma Co., Ltd.
  • 7. Mitsubishi Tanabe Pharma Corporation
  • 8. Nichi-Iko Pharmaceutical Co., Ltd.
  • 9. Nipro Corporation
  • 10. Otsuka Pharmaceutical Co., Ltd.
  • 11. Sawai Pharmaceutical Co., Ltd.
  • 12. Shionogi & Co., Ltd.
  • 13. Takeda Pharmaceutical Company Limited
  • 14. Teijin Pharma Limited
  • 15. Towa Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. BENEXATE MARKET RESEARCH PROCESS
  • FIGURE 2. BENEXATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BENEXATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BENEXATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BENEXATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BENEXATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BENEXATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BENEXATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BENEXATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BENEXATE MARKET DYNAMICS
  • TABLE 7. GLOBAL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BENEXATE MARKET SIZE, BY BENEXATE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BENEXATE MARKET SIZE, BY BENEXATE HYDROCHLORIDE BETADEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BENEXATE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BENEXATE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BENEXATE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BENEXATE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BENEXATE MARKET SIZE, BY GASTRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BENEXATE MARKET SIZE, BY PEPTIC ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BENEXATE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BENEXATE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BENEXATE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BENEXATE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BENEXATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BENEXATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BENEXATE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BENEXATE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BENEXATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BENEXATE MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BENEXATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. BENEXATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. BENEXATE MARKET, FPNV POSITIONING MATRIX, 2023